Bank of Montreal’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-9,132
| Closed | -$886K | – | 5108 |
|
|
2019
Q3 | $886K | Buy |
9,132
+1,156
| +14% | +$116K | ﹤0.01% | 2136 |
|
|
2019
Q2 | $817K | Buy |
7,976
+3,899
| +96% | +$421K | ﹤0.01% | 2174 |
|
|
2019
Q1 | $465K | Sell |
4,077
-1,934
| -32% | -$142K | ﹤0.01% | 2341 |
|
|
2018
Q4 | $236K | Buy |
6,011
+2,758
| +85% | +$120K | ﹤0.01% | 2493 |
|
|
2018
Q3 | $177K | Buy |
3,253
+2,969
| +1,045% | +$203K | ﹤0.01% | 2821 |
|
|
2018
Q2 | $23K | Buy |
284
+223
| +366% | +$17.2K | ﹤0.01% | 3698 |
|
|
2018
Q1 | $4K | Sell |
61
-400
| -87% | -$23.1K | ﹤0.01% | 3973 |
|
|
2017
Q4 | $24K | Buy |
461
+400
| +656% | +$28.7K | ﹤0.01% | 3539 |
|
|
2017
Q3 | $5K | Hold |
61
| – | – | ﹤0.01% | 3879 |
|
|
2017
Q2 | $4K | Sell |
61
-102
| -63% | -$5.7K | ﹤0.01% | 3925 |
|
|
2017
Q1 | $9K | Hold |
163
| – | – | ﹤0.01% | 3592 |
|
|
2016
Q4 | $9K | Buy |
163
+102
| +167% | +$5.46K | ﹤0.01% | 3640 |
|
|
2016
Q3 | $4K | Hold |
61
| – | – | ﹤0.01% | 3772 |
|
|
2016
Q2 | $3K | Buy |
+61
| New | +$2.61K | ﹤0.01% | 3863 |
|
Bank of Montreal's ONCE Position: Q4 2019 in Review
Bank of Montreal sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 9,132 shares — an estimated $886K sold.
Bank of Montreal first reported a position in ONCE in Q2 2016 and held it in 14 quarters. The position peaked at $886K in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Bank of Montreal reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Bank of Montreal sold 9,132 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $886K.
- Bank of Montreal first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2016 and held it in 14 quarters.
- Bank of Montreal's Spark Therapeutics, Inc. Common Stock position peaked at $886K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Bank of Montreal's 13F filing for Q4 2019, filed 10 Feb 2020.